The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: LAMIVUDINE.     Injury: Blood creatine phosphokinase increased     Quarter: 2016Q3

  |<   1/2   << Previous Page   Page 1  

Total Records: 7     Number of Pages: 1

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
123393654 LAMIVUDINE. Blood creatine phosphokinase increased GILEAD 47.00 YR M 0 20160714 CN
123409894 LAMIVUDINE. Blood creatine phosphokinase increased VIIV 47.00 YR M 0 20160719 CN
123425464 LAMIVUDINE. Blood creatine phosphokinase increased GLAXOSMITHKLINE 47.00 YR M 0 20160719 CN
125297361 LAMIVUDINE. Blood creatine phosphokinase increased LUPIN 0.00 UNK 0 20160706 DE
125441111 LAMIVUDINE. Blood creatine phosphokinase increased GLAXOSMITHKLINE 47.00 YR M 0 20160711 CN
125447831 LAMIVUDINE. Blood creatine phosphokinase increased VIIV 47.00 YR M 0 20160711 CN
126925781 LAMIVUDINE. Blood creatine phosphokinase increased CIPLA 0.00 0 20160829 IT

  |<   1/2   << Previous Page   Page 1  

Total Records: 7     Number of Pages: 1

Execution Time: 0.015902042388916 seconds (ucode:5253507). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.